2017
-
Vinicius Ernani, MD
Vinicius Ernani has been appointed Assistant Professor at the Fred and Pamela Buffett Cancer Center of the University of Nebraska, Omaha, NE. Previous to this appointment, Dr. Ernani completed a hematology/oncology […]
-
Breaking News Briefs
• The global, randomized phase III ALEX study was announced to have met its primary endpoint, demonstrating that alectinib (Alecensa), as an initial (first-line) treatment, significantly reduced the risk of […]
-
Innovations in the 8th Edition of the TNM Classification of Lung Cancer Enhance Prognostic Capabilities
Posted: April 2017 By Cynthia L. Kryder, MS, CCC-Sp, with Ramón Rami-Porta, MD Clinicians around the world began implementing the 8th edition of the tumor, node, and metastasis (TNM) classification […]
-
Efforts Aim to Make Clinical Trial Information More Accessible
Posted: February 2017 By Cynthia L. Kryder, MS Clinical trials are essential to the development of new, potentially lifesaving therapies for patients with cancer. Well-designed clinical trials contribute to medical […]
-
Role of Nurses in the Care of Patients with Lung Cancer
Posted: February 2017 By Lori Alexander, MTPW, ELS, MWC WCLC 2016 offered focused education for nurses and allied health professionals through its nursing track, as well as through special nursing […]
-
A Life in Thoracic Oncology – Reflections from Giants on Milestones in the Treatment Advances in Lung Cancer
Posted: February 2017 By Lori Alexander, MTPW, ELS, MWC The closing plenary session at IASLC WCLC 2016 featured several highly regarded oncologists who have devoted the greater part of their […]
-
Drug Approval Processes Around the World: Focus on China
Posted: February 2017 By Caicun Zhou, MD As part of an ongoing series, IASLC Lung Cancer News is exploring how drug approval processes differ country by country, and continent by […]
-
The Fourth IASLC Screening Strategy Advice Committee CT Screening Workshop
Posted: February 2017 By John K. Field, PhD, FRCPath, and James L. Mulshine, MD, PhD The Fourth IASLC Screening Strategy Advice Committee (SSAC) computed tomography (CT) screening workshop was held […]
-
Impact of Clinical Pathways on Lung Cancer Management
Posted: February 2017 Q&A with with Ronan J. Kelly, MB BCh, MBA Q: What is the impetus for the development of clinical pathways? A: The incidence of cancer in the US […]
-
Breaking News Briefs
Alectinib (Alecensa) received a positive opinion from the European Medicines Agency (EMA) for Medicinal Products for Human Use (CHMP) for the treatment of adult patients with advanced anaplastic lymphoma kinase […]
View ILCN Archives
Provider Resources